FIVE vs UTHR · P/E 28, rev $1.39B vs P/E 20, rev $2.88B
Five Below Inc (FIVE) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Five Below Inc (FIVE) is a specialty retail company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported FIVE revenue for 2025-02-01 was $1.39B. Net income was $187.5M. Revenue was up 64.9% from 2024-11-02 to 2025-02-01. FIVE currently screens at market cap $7.30B and trailing P/E 27.7.
Latest reported UTHR revenue for 2024-12-31 was $2.88B. Net income was $1.20B. Revenue was up 23.6% from 2023-12-31 to 2024-12-31. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
FIVE currently screens at market cap $7.30B and trailing P/E 27.7. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the FIVE and UTHR stock pages for the full models.
Not investment advice.